cellvie
PrivateLast Round
Seed
Feb 6, 2023
Total Funding Raised
$16M
Company Overview
cellvie is a biotechnology company that develops mitochondria-based therapeutic technology intended to restore cellular bioenergetics and improve organ function.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
cellvie Comps
Public and private peers based on sector, stage, and business model.
cellvie Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 6, 2023 | ||||
| Seed | Feb 6, 2023 | ||||
| Seed | Jan 25, 2021 |
cellvie Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kizoo Technology Capital | Seed |
| Taiho Ventures | Seed |
| Oscar & Paul Beiersdorf Venture Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 133% MoM.
- Nov 7, 2025
Monthly visitors increased 229% MoM.
cellvie Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about cellvie's valuation, stock price, and market status.
